Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal
- 1 February 1986
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 143 (2) , 235-236
- https://doi.org/10.1176/ajp.143.2.235
Abstract
Alprazolam treatment is effective for panic disorder, but its major disadvantages include possible dependence and withdrawal symptoms upon discontinuation. The authors report three cases in which carbamazepine, a clinically effective anticonvulsant without abuse potential, successfully attenuated alprazolam withdrawal symptoms.This publication has 8 references indexed in Scilit:
- Differential mediation of the anticonvulsant effects of carbamazepine and diazepamLife Sciences, 1985
- Some Biochemical Correlates of Panic Attacks with Agoraphobia and Their Response to a New TreatmentJournal of Clinical Psychopharmacology, 1984
- Prophylactic efficacy of carbamazepine in manic-depressive illnessAmerican Journal of Psychiatry, 1983
- A controlled clinical trial of alprazolam for the treatment of anxietyAmerican Journal of Psychiatry, 1983
- Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled studyPsychopharmacology, 1982
- AMBULANT TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS WITH CARBAMAZEPINE: A FORMAL MULTICENTRE DOUBLE‐BLIND COMPARISON WITH PLACEBOActa Psychiatrica Scandinavica, 1976
- The Effects of Carbamazepine on Patients with Psychomotor Epilepsy: Results of a Double‐Blind StudyEpilepsia, 1974
- TRIGEMINAL NEURALGIA: ITS TREATMENT WITH A NEW ANTICONVULSANT DRUG (G-32883)The Lancet, 1962